Author: admin

Northwestern Medicine scientists have discovered that mutations in the SCN2A gene, previously linked to epilepsy and autism, are also a hidden cause of a rare, severe form of migraine characterized by temporary one-sided paralysis. This finding reinforces the understanding of migraines as disorders of brain excitability and is expected to immediately improve genetic diagnosis and counseling for affected families.

A new study reveals that personalized deep brain stimulation shows significant promise for individuals with drug-resistant epilepsy, not only reducing seizures but also improving memory and sleep. By continuously monitoring brain activity with AI and adjusting stimulation in real-time, researchers at Mayo Clinic are paving the way for more effective and tailored treatments for this challenging condition.

An innovative AI tool can now detect brain lesions frequently missed by doctors, potentially revolutionizing epilepsy diagnosis, particularly for medication-resistant cases. This technology, by identifying subtle abnormalities in brain scans, promises to expedite diagnosis and treatment, offering new hope for patients and reducing the need for extensive testing.